Statistics about Health, Pharma & Medtech in Sweden
Statistics
- BONESUPPORT HOLDING net income 2021-2025
- BONESUPPORT HOLDING total equity 2021-2025
- BONESUPPORT HOLDING revenue 2021-2025
- BONESUPPORT HOLDING net cash 2021-2025
- BICO Group liabilities 2021-2025
- BONESUPPORT HOLDING operating profit 2021-2025
- BONESUPPORT HOLDING gross profit 2021-2025
- BICO Group total assets 2021-2025
- BICO Group net cash 2021-2025
- BICO Group net income 2021-2025
- BICO Group revenue 2021-2025
- BICO Group gross profit 2021-2025
- BICO Group operating profit 2021-2025
- BICO Group total equity 2021-2025
- Attendo revenue 2021-2025
- Attendo net income 2021-2025
- Attendo total assets 2021-2025
- Attendo liabilities 2021-2025
- Attendo net cash 2021-2025
- Attendo operating profit 2021-2025
- Attendo total equity 2021-2025
- Ascelia Pharma liabilities 2021-2025
- Ascelia Pharma total assets 2021-2025
- Ascelia Pharma net income 2021-2025
- Ascelia Pharma net cash 2021-2025
- Ascelia Pharma operating profit 2021-2025
- Ascelia Pharma total equity 2021-2025
- Arjo AB liabilities 2021-2025
- Arjo AB total equity 2021-2025
- Arjo AB net cash 2021-2025
- Arjo AB total assets 2021-2025
- Arjo AB net income 2021-2025
- Arjo AB revenue 2021-2025
- Arjo AB operating profit 2021-2025
- Arjo AB gross profit 2021-2025
- Alligator Bioscience liabilities 2021-2025
- Alligator Bioscience net income 2021-2025
- Alligator Bioscience total assets 2021-2025
- Alligator Bioscience total equity 2021-2025
- Alligator Bioscience net cash 2021-2025
- Alligator Bioscience operating profit 2021-2025
- Alligator Bioscience revenue 2021-2025
- AddLife AB net income 2021-2025
- AddLife AB total assets 2021-2025
- AddLife AB liabilities 2021-2025
- AddLife AB revenue 2021-2025
- AddLife AB net cash 2021-2025
- AddLife AB total equity 2021-2025
- Active Biotech liabilities 2021-2025
- Active Biotech net income 2021-2025
- AddLife AB gross profit 2021-2025
- AddLife AB operating profit 2021-2025
- Active Biotech total assets 2021-2025
- Active Biotech net cash 2021-2025
- Active Biotech operating profit 2021-2025
- Ambea AB total assets 2021-2025
- Ambea AB liabilities 2021-2025
- Ambea AB net income 2021-2025
- Ambea AB total equity 2021-2025
- Ambea AB net cash 2021-2025
- Ambea AB revenue 2021-2025
- Ambea AB gross profit 2021-2025
- Ambea AB operating profit 2021-2025
- Vivesto net cash 2020-2024
- Vivesto operating profit 2020-2024
- Vivesto total assets 2020-2024
- Vivesto net income 2020-2024
- Vivesto liabilities 2020-2024
- Vivesto total equity 2020-2024
- Isofol Medical total assets 2020-2024
- Isofol Medical liabilities 2020-2024
- Isofol Medical net income 2020-2024
- Isofol Medical net cash 2020-2024
- Isofol Medical operating profit 2020-2024
- Isofol Medical total equity 2020-2024
- Active Biotech total equity 2020-2024
- Vivesto revenue 2019 to 2023
- Vivesto gross profit 2019 to 2023
- Probi AB liabilities 2019 to 2023
- Probi AB net income 2019 to 2023
- Probi AB total equity 2019 to 2023
- Probi AB total assets 2019 to 2023
- Probi AB net cash 2019 to 2023
- Probi AB revenue 2019 to 2023
- Probi AB gross profit 2019 to 2023
- Probi AB operating profit 2019 to 2023
- Ortivus liabilities 2019 to 2023
- Ortivus net income 2019 to 2023
- Ortivus total assets 2019 to 2023
- Ortivus total equity 2019 to 2023
- Ortivus revenue 2019 to 2023
- Ortivus net cash 2019 to 2023
- Ortivus operating profit 2019 to 2023
- Ortivus gross profit 2019 to 2023
- Isofol Medical revenue 2019 to 2023
- IRLAB Therapeutics gross profit 2021 to 2022
- Biotage AB liabilities 2019 to 2023
- Biotage AB total assets 2019 to 2023
- Biotage AB net income 2019 to 2023
- Biotage AB total equity 2019 to 2023